Literature DB >> 17322878

A module of negative feedback regulators defines growth factor signaling.

Ido Amit1, Ami Citri, Tal Shay, Yiling Lu, Menachem Katz, Fan Zhang, Gabi Tarcic, Doris Siwak, John Lahad, Jasmine Jacob-Hirsch, Ninette Amariglio, Nora Vaisman, Eran Segal, Gideon Rechavi, Uri Alon, Gordon B Mills, Eytan Domany, Yosef Yarden.   

Abstract

Signaling pathways invoke interplays between forward signaling and feedback to drive robust cellular response. In this study, we address the dynamics of growth factor signaling through profiling of protein phosphorylation and gene expression, demonstrating the presence of a kinetically defined cluster of delayed early genes that function to attenuate the early events of growth factor signaling. Using epidermal growth factor receptor signaling as the major model system and concentrating on regulation of transcription and mRNA stability, we demonstrate that a number of genes within the delayed early gene cluster function as feedback regulators of immediate early genes. Consistent with their role in negative regulation of cell signaling, genes within this cluster are downregulated in diverse tumor types, in correlation with clinical outcome. More generally, our study proposes a mechanistic description of the cellular response to growth factors by defining architectural motifs that underlie the function of signaling networks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322878     DOI: 10.1038/ng1987

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  228 in total

1.  Systematic discovery of TLR signaling components delineates viral-sensing circuits.

Authors:  Nicolas Chevrier; Philipp Mertins; Maxim N Artyomov; Alex K Shalek; Matteo Iannacone; Mark F Ciaccio; Irit Gat-Viks; Elena Tonti; Marciela M DeGrace; Karl R Clauser; Manuel Garber; Thomas M Eisenhaure; Nir Yosef; Jacob Robinson; Amy Sutton; Mette S Andersen; David E Root; Ulrich von Andrian; Richard B Jones; Hongkun Park; Steven A Carr; Aviv Regev; Ido Amit; Nir Hacohen
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 2.  The roles of TTP and BRF proteins in regulated mRNA decay.

Authors:  Sandhya Sanduja; Fernando F Blanco; Dan A Dixon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 Jan-Feb       Impact factor: 9.957

3.  A strategy for building an amplified transcriptional switch to detect bacterial contamination of plants.

Authors:  Eva Czarnecka; F Lance Verner; William B Gurley
Journal:  Plant Mol Biol       Date:  2011-11-25       Impact factor: 4.076

4.  A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Authors:  Aldema Sas-Chen; Roi Avraham; Yosef Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-12       Impact factor: 2.673

Review 5.  The ERBB network: at last, cancer therapy meets systems biology.

Authors:  Yosef Yarden; Gur Pines
Journal:  Nat Rev Cancer       Date:  2012-07-12       Impact factor: 60.716

Review 6.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.

Authors:  Walter Kolch; Andrew Pitt
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

7.  Transcription factors, coregulators, and epigenetic marks are linearly correlated and highly redundant.

Authors:  Tobias Ahsendorf; Franz-Josef Müller; Ved Topkar; Jeremy Gunawardena; Roland Eils
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

8.  Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells.

Authors:  Imoh S Okon; Kathleen A Coughlan; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

9.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

10.  An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

Authors:  S Carvalho; M Lindzen; M Lauriola; N Shirazi; S Sinha; A Abdul-Hai; K Levanon; J Korach; I Barshack; Y Cohen; A Onn; G Mills; Y Yarden
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.